IPF is a life-threatening lung disease with no known cause. Over time, the lungs become scarred, making it harder to breathe. More than 250,000 Americans are living with IPF and other interstitial ...

British lender International Personal Finance said on Monday it has agreed to a 543 million-pound ($732.51 million) takeover by a company associated with BasePoint Capital, finalising terms ahead of a ...

Under the terms of the offer, IPF shareholders will receive 235 pence in cash for each share, valuing the provider of credit products and insurance services at around GBP543 million. IPF shares closed ...

New York-headquartered BasePoint Capital will pay 235p a share in cash for the Leeds-based consumer loans firm.

Achieving equitable access to anti-fibrotic drugs requires multi-stakeholder collaboration, while the most critical unmet ...

OPEN The FTSE 100 was expected to open 7.4 points higher ahead of the bell on Monday after wrapping up the previous session 0.19% weaker at 9,870.68.

Discover how weather conditions affect idiopathic pulmonary fibrosis (IPF) symptoms and learn practical tips to manage your ...

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...

The findings are part of a new wave of research that uses artificial intelligence (AI) to hasten scientific discovery. IPF is marked by declining lung function and eventual respiratory failure. It ...

International Personal Finance said the U.K. takeover panel agreed to extend the deadline for BasePoint Capital to announce a firm intention to make an offer. IPF and U.S. peer BasePoint have been in ...

Long-held dogma says lung fibrosis in diseases like idiopathic pulmonary fibrosis, or IPF, results from recurrent injury to alveolar epithelium that is followed by dysregulated repair. Research at the ...

Please provide your email address to receive an email when new articles are posted on . Saracatinib appeared to be “equal or superior” in stopping fibrotic responses compared with two FDA-approved ...